Noninvasive methods for detection of organ fibrosis

Connective Tissue in Health and Disease

Volumn , Issue , 2017, Pages 61-98

  Risteli, Leila ^a   Risteli, Juha ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85053093250     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781315150512     Document Type: Chapter

References (178)

1. Peters, J. H., Ginsberg, M. H., Bohl, B. P., Sklar, L. A., and Cochrane, C. G., Intravascular release of intact cellular fibronectin during oxidant-induced injury of the in vitro perfused rabbit lung, J. Clin. Invest., 78, 1596, 1986.
2. Hahn, E. G., Blood analysis for liver fibrosis, J. Hepatol., 1, 67, 1984.
3. Beaugrand, M., Quand et comment mesurer la fibrose hepatique?, Gastroenterol. Clin. Biol., 9, 235, 1985.
4. Hahn, E. G. and Schuppan, D., Ethanol and fibrogenesis in the liver, in Alcohol Related Diseases in Gastroenterology, Seitz, H. K. and Kommerell, B., Eds., Springer-Verlag, Berlin, 1985, 124.
5. Gressner, A. M., Measurement of connective tissue parameters in serum for diagnosis and follow-up of liver fibrosis, Ann. Clin. Biochem., 24, 283, 1987.
6. Risteli, L. and Risteli, J., Radioimmunoassays for monitoring connective tissue metabolism, Rheumatology, 10, 216, 1986.
7. Risteli, L. and Risteli, J., Assessment of type IV collagen and laminin metabolism by radioimmunoassays, in Renal Basement Membranes in Health and Disease, Price, R. G. and Hudson, B. G., Eds., Academic Press, London, 1987, 219.
8. Risteli, L. and Risteli, J., Analysis of extracellular matrix proteins in biological fluids, Methods Enzymol., 145, 391, 1987.
9. Laurent, G. J., Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass, Am. J. Physiol., 252, CI, 1987.
10. Miyahara, M., Njieha, F. K., and Prockop, D. J., Formation of collagen fibrils in vitro by cleavage of procollagen with procollagen proteinases, J. Biol. Chem., 257, 8442, 1982.
11. Davis, B. H. and Madri, J. A., An immunohistochemical and serum ELISA study of type I and III procollagen aminopropeptides in primary biliary cirrhosis, Am. J. Pathol., 128, 265, 1987.
12. Fisher, L. W., Robey, P. G., Tuross, N., Otsuka, A. S., Tepen, D. A., Esch, F. S., Shimasaki, S., and Termine, J. D., The M, 24,000 phosphoprotein from developing bone is the NH2-terminal propeptide of the ctl chain of type I collagen, J. Biol. Chem., 262, 13457, 1987.
13. Van der Rest, M., Rosenberg, L. C., Olsen, B. R., and Poole, A. R., Chondrocalcin is identical with the C-propeptide of type II procollagen, Biochem. J., 237, 923, 1986.
14. Hinek, A., Reiner, A., and Poole, A. R., The calcification of cartilage matrix in chondrocyte culture: studies of the C-propeptide of type II collagen (chondrocalcin), J. Cell Biol., 104, 1435, 1987.
15. Rohde, H., Vargas, L., Hahn, E., Kalbfleisch, H., Bruguera, M., and Timpi, R., Radioimmunoassay for type III procollagen peptide and its application to human liver disease, Eur. J. Clin. Invest., 9, 451, 1979.
16. Rojkind, M., The blue glass and the predictive value of serum amino-terminal propeptide of type III procollagen as a marker of liver fibrosis, Hepatology, 4, 977, 1984.
17. Niemelä, O., Risteli, L., Sotaniemi, E. A., and Risteli, J., Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease, Gastroenterology, 85, 254, 1983.
18. Risteli, L., Kauppila, A., Makila, U. -M., and Risteli, J., Aminoterminal propeptide of type III procollagen in serum - an indicator of clinical behaviour of advanced ovarian carcinoma?, Int. J. Cancer, 41, 409, 1988.
19. Risteli, J., Niemi, S., Trivedi, P., Maentausta, O., Mowat, A. P., and Risteli, L., Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen, Clin. Chem., 34, 715, 1988.
20. Niemelä, O., Risteli, L., and Risteli, J., unpublished.
21. Niemelä, O., Risteli, L., Parkkinen, J., and Risteli, J., Purification and characterization of the N-terminal propeptide of human type III procollagen, Biochem. J., 232, 145, 1985.
22. Bjermer, L., Thunell, M., and Hallgren, R., Procollagen III peptide in bronchoalveolar lavage fluid. A potential marker of altered collagen synthesis reflecting pulmonary disease in sarcoidosis, Lab. Invest., 55, 654, 1986.
23. Raedsch, R., Stiehl, A., Sieg, A., Walker, S., and Kommerell, B., Biliary excretion of procollagen type III peptide in healthy humans and in patients with alcoholic cirrhosis of the liver, Gastroenterology, 85, 1265, 1983.
24. Gressner, A. M., Aminoterminal propeptides of type III procollagen in human cerebrospinal fluid, J. Clin. Chem. Clin. Biochem., 22, 237, 1984.
25. Gressner, A. M. and Neu, H. -H., Amino-terminal propeptides of type III procollagen in seminal fluid, Clin. Chem., 30, 488, 1984.
26. 2-microglobulin in synovial fluids from inflammatory and non-inflammatory joint diseases, Clin. Chim. Acta, 141, 241, 1984.
27. Rohde, H., Langer, I., Krieg, T., and Timpl, R., Serum and urine analysis of the aminoterminal procollagen peptide type III by radioimmunoassay with antibody Fab fragments, Collagen Relat. Res., 3, 371, 1983.
28. Haukipuro, K., Risteli, L., Kairaluoma, M. I., and Risteli, J., Aminoterminal propeptide of type III procollagen in healing wound in humans, Ann. Surg., 206, 752, 1987.
29. Rohde, H., Bruckner, P., and Timpl, R., Immunochemical properties of the aminopropeptide of procollagen type III, Eur. J. Biochem., 135, 197, 1983.
30. Galambos, M. R., Collins, D. C, and Galambos, J. T., A radioimmunoassay procedure for type III procollagen: its use in the detection of hepatic fibrosis, Hepatology, 5, 38, 1985.
31. Niemelä, O., Radioimmunoassays for type III procollagen amino-terminal peptides in humans, Clin. Chem., 31, 1301, 1985.
32. Pierard, D., Nusgens, B. V., and Lapiere, C. M., Radioimmunoassay for the aminoterminal sequences of type III procollagen in human body fluids measuring fragmented precursor sequences, Anal. Biochem. 141, 127, 1984.
33. Hartmann, D. et al., unpublished.
34. Ackermann, W., Pott, G., Voss, B., Miiller, K. -M., and Gerlach, U., Serum concentration of pro-collagen-m-peptide in comparison with the serum activity of A'-acetyl-β-glucosaminidase for diagnosis of the activity of liver fibrosis in patients with chronic active liver disease, Clin. Chim. Acta, 112, 365, 1981.
35. Niemelä, O., Risteli, L., Sotaniemi, E. A., and Risteli, J., Heterogeneity of the antigens related to the amino-terminal propeptide of type III procollagen in human serum, Clin. Chim. Acta, 124, 39, 1982.
36. Schuppan, D” Dumont, J. M., Kim, K. Y., Hennings, G., and Hahn, E. G., Serum concentration of the aminoterminal procollagen type III peptide in the rat reflects early formation of connective tissue in experimental liver cirrhosis, J. Hepatol., 3, 27, 1986.
37. Savolainen, E.-R., Brocks, D., Ala-Kokko, L., and Kivirikko, K. I., Serum concentrations of the N-terminal propeptide of type III procollagen and two type IV collagen fragments and gene expression of the respective collagen types in liver in rats with dimethylnitrosamine-induced hepatic fibrosis, Biochem. J., 249, 753, 1988.
38. Davis, B. H. and Madri, J. A., Type I and type III procollagen peptides during hepatic fibrogenesis. An immunohistochemical and ELISA serum study in the CC14 rat model, Am. J. Pathol., 127, 137, 1987.
39. Wick, G., Brunner, H., Penner, E., and Timpl, R., The diagnostic application of specific antiprocollagen sera. II. Analysis of liver biopsies, Int. Arch. Allergy Appl. Immunol., 56, 316, 1978.
40. Fleischmajer, R., Perlish, J. S., and Timpl, R., Collagen fibrillogenesis in human skin, in Biology, Chemistry, and Pathology of Collagen, Fleischmajer, R., Olsen, B. R., and Kiihn, K., Eds., New York Academy of Sciences, New York, 1985, 246.
41. Karttunen, T., Sormunen, R.. Risteli, L., Risteli, J., and Autio-Harmainen, H., Immunoelectron microscopic localization of laminin, type IV collagen and type III pN-collagen in reticular fibers of human lymph nodes, J. Histochem. Cytochem., 37, 279, 1989.
42. Bowness, J. M., Folks, J. E., and Timpl, R., Identification of a substrate site for liver transglutaminase on the aminopropeptide of type III collagen, J. Biol. Chem., 262, 1022, 1987.
43. Smedsrød, B., Aminoterminal propeptide of type III procollagen is cleared from the circulation by receptor-mediated endocytosis in liver endothelial cells, Collagen Relat. Res., 8, 375, 1988.
44. Bentsen, K. D., Boesby, S., Kirkegaard, P., Hansen, C. P., Jensen, S. L., Hørslev-Petersen, K., and Lorenzen, I., Is the aminoterminal propeptide of type III procollagen degraded in the liver? A study of type III procollagen peptide in serum during liver transplantation in pigs, J. Hepatol., 6, 144, 1988.
45. Gressner, A. M., Kropf, J., and Tittor, W., Estimation of the production rates of serum aminoterminal propeptide of type III procollagen and laminin in human fibrotic liver, J. Clin. Chem. Clin. Biochem., 25, 553, 1987.
46. Bentsen, K. D., Henriksen, J. H., Boesby, S., Hørslev-Petersen, K., and Lorenzen, I., Hepatic and renal extraction of circulating type III procollagen aminoterminal propeptide and hyaluronan in pig, J. Hepatol., in press.
47. Bentsen, K. D., Henriksen, J. H., Bendtsen, F., Hørslev-Petersen, K., and Lorenzen, I., Splanchnic and renal extraction of circulating type III procollagen aminoterminal propeptide in patients with normal liver function and in patients with alcoholic cirrhosis, Hepatology, in press.
48. Taubman, M. B., Goldberg, B., and Sherr, C. J., Radioimmunoassay for human procollagen, Science, 186, 1115, 1974.
49. Taubman, M. B., Kammerman, S., and Goldberg, B., Radioimmunoassay of procollagen in serum of patients with Paget‘s disease of bone, Proc. Soc. Exp. Biol. Med., 152, 284, 1976.
50. Carey, D. E., Goldberg, B., Ratzan, S. K., Rubin, K. R., and Rowe, D. W” Radioimmunoassay for type I procollagen in growth hormone-deficient children before and during treatment with growth hormone, Pediatr. Res., 19, 8, 1985.
51. Simon, L. S., Krane, S. M., Wortman, P. D., Krane, I. M., and Kovitz, K. L., Serum levels of type I and III procollagen fragments in Paget‘s disease of bone, J. Clin. Endocrinol. Metab., 58, 110, 1984.
52. Savolainen, E. -R., Goldberg, B., Leo, M. A., Velez, M., and Lieber, C. S., Diagnostic value of serum procollagen peptide measurements in alcoholic liver disease, Alcohol Clin. Exp. Res., 8, 384, 1984.
53. Parfitt, A. M., Simon, L. S., Villaneuva, A. R., and Krane, S. M., Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with iliac bone formation rates and comparison with total alkaline phosphatase, J. Bone Mineral Res., 2, 427, 1987.
54. Melkko, J., Risteli, L., and Risteli, J., unpublished.
55. Haukipuro, K., Melkko, J., Risteli, L., Kairaluoma, M., and Risteli, J., unpublished.
56. McDonald, J. A., Broekelmann, T. J., Matheke, M. L., Crouch, E., Koo, M., and Kuhn, C, III., A monoclonal antibody to the carboxyterminal domain of procollagen type I visualizes collagen-synthesizing fibroblasts. Detection of an altered fibroblast phenotype in lungs of patients with pulmonary fibrosis, J. Clin. Invest., 78, 1237, 1986.
57. Rohde, H. U., Nowack, H., Becker, U., and Timpl, R., Radioimmunoassay for the aminoterminal peptide of procollagen pal(I)-chain, J. Immunol. Methods, 11, 135, 1976.
58. Rojkind, M. and Pérez-Tamayo, R., Liver fibrosis, Int. Rev. Connect. Tissue Res., 10, 333, 1983.
59. Hahn, E. G., Wick, G., Pencev, D., and Timpl, R., Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin and fibronectin, Gut, 21, 63, 1980.
60. Timpl, R., Recent advances in the biochemistry of glomerular basement membrane, Kidney Int., 30, 293, 1986.
61. Risteli, J., Wick, G-, and Timpl, R., Immunological characterization of the 7-S domain of type IV collagens. Collagen Relat. Res., 5, 419, 1981.
62. Högemann, B., Voss, B., Pott, G., Rauterberg, J., and Gerlach, U., 7S collagen: a method for the measurement of serum concentrations in man, Clin. Chim. Acta, 144, 1, 1984.
63. Niemelä, O., Risteli, L., Sotaniemi, E. A., and Risteli, J., Type IV collagen and laminin-related antigens in human serum in alcoholic liver disease, Eur. J. Clin. Invest., 15, 132, 1985.
64. Risteli, J., Draeger, K. E., Regitz, G., and Neubauer, H. P., Increase in circulating basement membrane antigens in diabetic rats and effects of insulin treatment, Diabetologia, 23, 266, 1982.
65. Risteli, J., Rohde, H., and Timpl, R., Sensitive assays for 7 S collagen and laminin: application to serum and tissue studies of basement membranes, Anal. Biochem., 113, 372, 1981.
66. Brocks, D. G., Neubauer, H. P., and Strecker, H., Type IV collagen antigens in serum of diabetic rats: a marker for basement membrane collagen biosynthesis, Diabetologia, 28, 928, 1985.
67. Schuppan, D., Besser, M., Schwarting, R., and Hahn, E. G., Radioimmunoassay for the carboxy-terminal cross-linking domain of type IV (basement membrane) procollagen in body fluids, J. Clin. Invest., 78, 241, 1986.
68. Brocks, D. G., Strecker, H., Neubauer, H. P., and Timpl, R., Radioimmunoassay of laminin in serum and its application to cancer patients, Clin. Chem., 32, 787, 1986.
69. Pick-Kober, K. H., Negwer, A., and Gressner, A. M., Determination of laminin in serum by a competitive radioimmunoassay directed against the pepsin-resistant fragment PI, J. Clin. Chem. Clin. Biochem., 23, 572, 1985.
70. Jukkola, A., Risteli, J., Autio-Harmainen, H., and Risteli, L., Effects of experimental nephrosis on basement-membrane components and enzymes of collagen synthesis in rat kidney, Biochem. J., 226, 243, 1985.
71. Hardingham, T. E., Structure and biosynthesis of proteoglycans, Rheumatology, 10, 143, 1986.
72. Engström-Laurent, A., Laurent, U. B. G., Lilja, K., and Laurent, T. C., Concentration of sodium hyaluronate in serum, Scand. J. Clin. Lab. Invest., 45, 497, 1985.
73. Frébourg, T., Delpech, B., Bercoff, E., Senant, J., Bertrand, P., Deugnier, Y., and Bourreille, J., Serum hyaluronate in liver diseases: study by enzymoimmunological assay, Hepatology, 6, 392, 1986.
74. Tengblad, A., Laurent, U. B. G., Lilja, K., Cahill, R. N. P., Engström-Laurent, A., Fraser, J. R. E., Hansson, H. E., and Laurent, T. C., Concentration and relative molecular mass of hyaluronate in lymph and blood, Biochem. J., 236, 5211, 1986.
75. Laurent, T. C, Dahl, I. M. S., Dahl, L. B., Engström-Laurent, A., Eriksson, S., Fraser, J. R. E., Granath, K. A., Laurent, C, Laurent, U. B. G., Lilja, K., Pertoft, H., Smedsrød, B., Tengblad, A., and Wik, O., The catabolic fate of hyaluronic acid, Connect. Tissue Res., 15, 33, 1986.
76. Smedsrød, B., Pertoft, H., Eriksson, S., Fraser, J. R. E., and Laurent, T. C., Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells, Biochem. J., 223, 617, 1984.
77. Bentsen, K. D., Henriksen, J. H., and Laurent, T. C., Circulating hyaluronate: concentration in different vascular beds in man, Clin. Sci., 71, 161, 1986.
78. Hällgren, R., Engström-Laurent, A., and Nisbeth, U., Circulating hyaluronate. A potential marker of altered metabolism of the connective tissue in uremia, Nephron, 46, 150, 1987.
79. Engström-Laurent, A. and Hällgren, R., Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy, Ann. Rheum. Dis., 44, 83, 1985.
80. Engström-Laurent, A., Feltelius, N., Hallgren, R., and Wasteson, Å., Elevated serum hyaluronate in scleroderma. An effect of growth factor-influenced activation of connective tissue cells?, Ann. Rheum. Dis., 44, 614, 1985.
81. Engström-Laurent, A., Lööf, L., Nyberg, A., and Schröder, T., Increased serum levels of hyaluronate in liver disease, Hepatology, 5, 638, 1985.
82. Schuppan, D., Ruhlmann, T., and Hahn, E. G., Radioimmunoassay for human type VI collagen and its application to tissue and body fluids, Anal. Biochem., 149, 238, 1985.
83. Darnule, T. V., McKee, M., Darnule, A. T., Turino, G. M., and Mandl, I., Solid-phase radioimmunoassay for estimation of elastin peptides in human sera, Anal. Biochem., 122, 302, 1982.
84. Koivu, J., Myllylä, R., Helaakoski, T., Pihlajaniemi, T., Tasanen, K., and Kivirikko, K. I., A single polypeptide acts both as the β subunit of prolyl 4-hydroxylase and as a protein disulfide-isomerase, J. Biol. Chem., 262, 6447, 1987.
85. Pihlajaniemi, T., Helaakoski, T., Tasanen, K., Myllylä, R., Huhtala, M.-L., Koivu, J., and Kivirikko, K. I., Molecular cloning of the β-subunit of human prolyl 4-hydroxylase. This subunit and protein disulphide isomerase are products of the same gene, EMBO J., 6, 643, 1987.
86. Cheng, S. -Y., Gong, Q. -H., Parkison, C, Robinson, E. A., Appella, E., Merlino, G. T., and Pastan, I., The nucleotide sequence of a human cellular thyroid hormone binding protein present in endoplasmic reticulum, J. Biol. Chem., 262, 11221, 1987.
87. Gressner, A. M. and Roebruck, P., Predictive values of serum N-acetyl-p-D-glucosaminidase for fibrotic liver disorders - correlation with monoamine oxidase activity, Clin. Chim. Acta, 124, 315, 1982.
88. Morelli, A., Vedovelli, A., Fiorucci, S., Angelini, G. P., Palmerini, C. A., and Floridi, A., Type III procollagen peptide and PZ-peptidase serum levels in precirrhotic liver diseases, Clin. Chim. Acta, 148, 87, 1985.
89. Kivirikko, K. I., Urinary excretion of hydroxyproline in health and disease, Int. Rev. Connect. Tissue Res., 5, 93, 1970.
90. Robins, S. P., Turnover and cross-linking of collagen, in Collagen in Health and Disease, Weiss, J. B. and Jayson, M. I. V., Eds., Churchill Livingstone, Edinburgh, 1982, 160.
91. Niell, H. B., Palmieri, G. M., Neely, C. L., Jr., and McDonald, M. W., Postabsorptive urinary hydroxyproline test in patients with metastatic bone disease from breast cancer, Arch. Intern. Med., 141, 1471, 1981.
92. Elomaa, I., Blomqvist, C., Gröhn, P., Porkka, L., Kairento, A.-L., Selander, K., Lamberg-Allardt, C., and Holmstrom, T., Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases, Lancet, 1, 146, 1983.
93. Gunja-Smith, Z. and Boucek, R. J., Collagen cross-linking compounds in human urine, Biochem. J., 197, 759, 1981.
94. Fujimoto, D., Suzuki, M., Uchiyama, A., Miyamoto, S., and Inoue, T., Analysis of pyridinolone, a crosslinking compound of collagen fibres, in human urine, J. Biochem., 94, 1133, 1983.
95. Robins, S. P., An enzyme-linked immunoassay for the collagen crosslink pyridinoline, Biochem. J., 207, 617, 1982.
96. Robins, S. P., Stewart, P., Astbury, C, and Brid, H. A., Measurement of the cross linking compound, pyridinoline, in urine as an index of collagen degradation in joint disease, Ann. Rheum. Dis., 45, 969, 1986.
97. Bentsen, K. D., Lanng, C, Hørslev-Petersen, K., and Risteli, J., The aminoterminal propeptide of type III procollagen and basement membrane components in serum during wound healing in man, Acta Chir. Scand., 154, 97, 1988.
98. Haukipuro, K., Risteli, L., Kairaluoma, M., and Risteli, J., unpublished.
99. Trivedi, P., Cheeseman, P., Portmann, B., Hegarty, J., and Mowat, A. P., Variation in serum type III procollagen peptide with age in healthy subjects and its comparative value in the assessment of disease activity in children and adults with chronic active hepatitis, Eur. J. Clin. Invest., 15, 69, 1985.
100. Trivedi, P., Risteli, J., Risteli, L., Tanner, M. S., Bhave, S., Pandit, A. N., and Mowat, A. P., Serum type III procollagen and basement membrane proteins as noninvasive markers of hepatic pathology in Indian childhood cirrhosis, Hepatology, 7, 1249, 1987.
101. Risteli, L., Puistola, U., Hohtari, H., Kauppila, A., and Risteli, J., Collagen metabolism in normal and complicated pregnancy: changes in the aminoterminal propeptide of type III procollagen in serum, Eur. J. Clin. Invest., 17, 81, 1987.
102. Bieglmayer, C, Feiks, A., and Rudelstorfer, R., Laminin in pregnancy, Gynecol. Obstet. Invest., 22, 7, 1986.
103. Raedsch, R., Stiehl, A., Waldherr, R., Mall, G., Gmelin, K., Gdtz, R., Walker, S., Czygan, P., and Kommerell, B., Procollagen-type III-peptide serum concentrations in chronic persistent and chronic active hepatis and in cirrhosis of the liver and their diagnostic value, Z. Gastroenterol., 20, 738, 1982.
104. Colombo, M., Annoni, G., Donato, M. F., Conte, D., Martines, D., Zaramella, M. G., Bianchi, P. A., Piperno, A., and Tiribelli, C., Serum type III procollagen peptide in alcoholic liver disease and idiopathic hemochromatosis: its relationship to hepatic fibrosis, activity of the disease and iron overload, Hepatology, 5, 475, 1985.
105. Monarca, A., Petrini, C, Perolini, S., Pozzi, F., Adelasco, L., Natangelo, R., and Crode, G., Procollagen-type III peptide serum concentrations in alcoholic and non-alcoholic liver disease, Ric. Clin. Lab., 15, 167, 1985.
106. Hartmann, D. J., Trinchet, J. C, Galet, B., Callard, P., Nusgens, B., Lapiere, C. M., Beaugrand, M., and Ville, G., Measurement of serum procollagen type III N terminal propeptide in patients with alcoholic liver disease, in Marker Proteins in Inflammation, Vol. 3, Bienvenu, Grimaud, and Laurent, Eds., Walter de Gruyter & Co., Berlin, 1986, 443.
107. Torres-Salinas, M., Pares, A., Caballeria J., Jimenez, W., Heredia, D., Bruguera, M., and Rodes, J., Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitis, Gastroenterology, 90, 1241, 1986.
108. Nouchi, T., Worner, T. M., Sato, S., and Lieber, C. S., Serum procollagen type III N-terminal peptides and laminin PI peptide in alcoholic liver disease, Alcohol Clin. Exp. Res., 11, 287, 1987.
109. Surrenti, C, Casini, A., Milani, S., Ambu, S., Ceccatelli, P., and D‘Agata, A., Is determination of serum N-terminal procollagen type III peptide (sPIIIP) a marker of hepatic fibrosis?, Dig. Dis. Sci., 32, 705, 1987.
110. Lu, W., Bantok, I., Desai, S., Lloyd, B., Hinks, L., and Tanner, A. R., Aminoterminal procollagen III peptide elevation in alcoholics who are selenium and vitamin E deficient, Clin. Chim. Acta, 154, 165, 1986.
111. Frei, A., Zimmermann, A., and Weigand, K., The N-terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease, Hepatology, 4, 830, 1984.
112. Sato, S., Nouchi, T., Worner, T. M., and Lieber, C. S., Liver fibrosis in alcoholics. Detection by Fab radioimmunoassay of serum procollagen III peptides, JAMA, 256, 1471, 1986.
113. Tanaka, Y., Minato, Y., Hasumura, Y., and Takeuchi, J., Evaluation of hepatic fibrosis by serum proline and amino-terminal type III procollagen peptide levels in alcoholic patients, Dig. Dis. Sci., 31, 712, 1986.
114. Bentsen, K. D., Horn, T., Risteli, J., Risteli, L., Engström-Laurent, A., Hørsiev-Petersen, K., Lorenzen, I., and the Copenhagen Study Group on Fibrotic Diseases, Serum aminoterminal type III procollagen peptide and the 7S domain of type IV collagen in patients with alcohol abuse. Relation to ultrastructural fibrosis in the acinar zone 3 and to serum hyaluronan, Liver, 7, 339, 1987.
115. Colombo, M., Annoni, G., Donato, M. F., Fargion, S., Tiribelli, C, and Dioguardi, N., Serum marker of type III procollagen in patients with idiopathic hemochromatosis and its relationship to hepatic fibrosis, Am. J. Clin. Pathol., 80, 499, 1983.
116. Bolarin, D. M., Savolainen, E. -R., and Kivirikko, K. I., Three serum markers of collagen biosynthesis in Nigerians with cirrhosis and various infectious diseases, Eur. J. Clin. Invest., 14, 90, 1984.
117. Annoni, G., Cargnel, A., Colombo, M., and Hahn, E. G., Persistent elevation of the aminoterminal peptide of procollagen type III in serum of patients with acute viral hepatitis distinguishes chronic active hepatitis from resolving or chronic persistent hepatitis, J. Hepatol., 2, 379, 1986.
118. Bentsen, K. D., Horslev-Petersen, K., Junker, P., Juhl, E., Lorenzen, I., and the Copenhagen Hepatitis Acuta Programme, Serum aminoterminal procollagen type III peptide in acute viral hepatitis. A long-term follow-up study, Liver, 7, 96, 1987.
119. Ballardini, G., Faccami, A., Bianchi, F. B., Fallani, M., Patrono, D., Capelli, M., and Pisi, E., Steroid treatment lowers hepatic fibroplasia, as explored by serum aminoterminal procollagen type III peptide, in chronic liver disease, Liver, 4, 348, 1984.
120. Weigand, K., Zaugg, P.-Y., Frei, A., and Zimmermann, A., Long-term follow-up of serum N-terminal propeptide of collagen type III levels in patients with chronic liver disease, Hepatology, 4, 835, 1984.
121. McCuliough, A. J., Stassen, W. N., Wiesner, R. H., and Czaja, A. J., Serum type III procollagen peptide concentrations in severe chronic active hepatitis: relationship to cirrhosis and disease activity, Hepatology, 7, 49, 1987.
122. McCuliough, A. J., Stassen, W. N., Wiesner, R. H., and Czaja, A. J., Serial determinations of the amino-terminal peptide of type III procollagen in severe chronic active hepatitis, J. Lab. Clin. Med., 109, 55, 1987.
123. Savolainen, E. -R., Miettinen, T. A., Pikkarainen, P., Salaspuro, M. P., and Kivirikko, K. I., Enzymes of collagen synthesis and type III procollagen aminopropeptide in the evaluation of D-penicillamine and medroxyprogesterone treatments of primary biliary cirrhosis, Gut, 24, 136, 1983.
124. Smith, A., Haboubi, N. Y., and Warnes, T. W., Serum procollagen-III-peptide concentration in primary biliary cirrhosis (PBC), Gut, 24, A503, 1983.
125. Eriksson, S. and Zettervall, O., The N-terminal propeptide of collagen type III in serum as a prognostic indicator in primary biliary cirrhosis, J. Hepatol., 2, 370, 1986.
126. Niemelä, O., Risteli, L., Sotaniemi, E. A., Stenbäck, F., and Risteli, J., Serum basement membrane and type III procollagen related antigens in primary biliary cirrhosis, J. Hepatol., 6, 307, 1988.
127. Bolarin, D. M., Savolainen, E.-R., and Kivirikko, K. I., Enzymes of collagen synthesis and type III procollagen amino-propeptide in serum from Nigerians with hepatocellular carcinoma and other malignant diseases, Int. J. Cancer., 29, 401, 1982.
128. Hatahara, T., Igarashi, S., and Funaki, N., High concentrations of N-terminal peptide of type III procollagen in the sera of patients with various cancers, with special reference to liver cancer, Gann, 75, 130, 1984.
129. El-Mohandes, M., Hassanein, H., El-Badwary, N., Voss, B., and Gerlach, U., Serum concentration of N-terminal procollagen peptide of collagen type III in schistosomal liver fibrosis, Exp. Mol. Pathol., 46, 383, 1987.
130. Risteli, J., Søgaard, H., Oikarinen, A., Risteli, L., Karvonen, J., and Zachariae, H., Aminoterminal propeptide of type III procollagen in methotrexate-induced liver fibrosis and cirrhosis, Br. J. Dermatol., 119, 321, 1988.
131. Trivedi, P., Cheeseman, P., Portmann, B., and Mowat, A. P., Serum type III procollagen peptide as a noninvasive marker of liver damage during infancy and childhood in extrahepatic biliary atresia, idiopathic hepatitis of infancy and alfal antitrypsin deficiency, Clin. Chim. Acta, 161, 137, 1986.
132. Gressner, A. M. and Tittor, W., Serum laminin - its concentration increases with portal hypertension in cirrhotic liver disease, Klin. Wochenschr., 64, 1242, 1986.
133. Gressner, A. M., Tittor, W., and Negwer, A., Serum concentrations of N-terminal propeptide of type III procollagen and laminin in the outflow of fibrotic livers compared with liver-distal regions, Hepato-gastroenterology, 33, 191, 1986.
134. Sotaniemi, E. A., Niemelä, O., Risteli, L., Stenbäck, F., Pelkonen, R. O., Lahtela, J. T., and Risteli, J., Fibrotic process and drug metabolism in alcoholic liver disease, Clin. Pharmacol. Ther., 40, 46, 1986.
135. Brocks, D. G., Bickel, M., and Engelbart, K., Type IV collagen antigens in serum of rats with experimental fibrosis of the liver, Alcohol Alcoholism Suppl., 1, 497, 1987.
136. Clark, J. G., Kuhn, C, III, McDonald, J. A., and Mecham, R. P., Lung connective tissue, Int. Rev. Connect. Tissue Res., 10, 249, 1983.
137. Low, R. B., Cutroneo, K. R., Davis, G. S., and Gianicola, M. S., Lavage type III procollagen N-terminal peptides in human pulmonary fibrosis and sarcoidosis, Lab. Invest., 48, 755, 1983.
138. Aresu, G., Pascalis, L., Pia, G., Rosetti, L., and Giglio, S., Procollagen III peptide in the blood and in the fluid of bronchoalveolar lavage of subjects affected by pulmonary fibrosis, IRCS Med. Sci., 14, 871, 1986.
139. Kirk, J. M. E., Bateman, E. D., Haslam, P. L., Laurent, G. J., and Turner-Warwick, M., Serum type III procollagen peptide concentration in cryptogenic fibrosing alveolitis and its clinical relevance, Thorax, 39, 726, 1984.
140. Anttinen, H., Terho, E. O., Myllyla, R., and Savolainen, E. -R., Two serum markers of collagen biosynthesis as possible indicators of irreversible pulmonary impairment in farmer‘s lung, Am. Rev. Respir. Dis., 133, 88, 1986.
141. Bjermer, L., Engstrom-Laurent, A., Lundgren, R., Rosenhall, L., and Hallgren, R., Hyaluronate and type III procollagen peptide concentrations in bronchoalveolar lavage fluid as markers of disease activity in farmer‘s lung, Br. Med. J., 295, 803, 1987.
142. Bégin, R., Martel, M., Desmarais, Y., Drapeau, G., Boileau, R., Rola-Pleszczynski, M., and Massé, S., Fibronectin and procollagen 3 levels in bronchoalveolar lavage of asbestos-exposed human subjects and sheep, Chest, 89, 237, 1986.
143. Hällgren, R., Eklund, A., Engström-Laurent, A., and Schmekel, B., Hyaluronate in bronchoalveolar lavage fluid: a new marker in sarcoidosis reflecting pulmonary disease, Br. Med. J., 290, 1778, 1985.
144. Watanabe, Y., Yamaki, K., Yamakawa, I., Takagi, K., and Satake, T., Type HI procollagen N-terminal peptides in experimental pulmonary fibrosis and human respiratory diseases, Eur. J. Respir. Dis., 67, 10, 1985.
145. Apaja-Sarkkinen, M., Autio-Harmainen, H., Alavaikko, M., Risteli, J., and Risteli, L., Immunohistochemical study of basement membrane proteins and type III procollagen in myelofibrosis, Br. J. Haematol., 63, 571, 1986.
146. Hochweiss, S., Fruchtman, S., Hahn, E. G., Gilbert, H., Donovan, P. B., Johnson, J., Goldberg, J. D., and Berk, P. D., Increased serum procollagen 111 aminoterminal peptide in myelofibrosis, Am. J. HematoL, 15, 343, 1983.
147. Vellenga, E., Mulder, N. H., van Zanten, A. K., Nieweg, H. O., and Woldring, M. G., The significance of the aminoterminal propeptide of type III procollagen in paroxysmal nocturnal haemoglobinuria and myelofibrosis, Eur. J. Nucl. Med., 8, 499, 1983.
148. Arrago, J. P., Poirier, O., and Najean, Y., Evolution des polyglobulies primitives vers la myelofibrose. Surveillance par le dosage de l‘amino-propeptide du procollagene III, Presse Med., 13, 2429, 1984.
149. Hasselbalch, H., Junker, P., Lisse, I., and Bentsen, K. D., Serum procollagen III peptide in chronic myeloproliferative disorders, Scand. J. Haematol., 35, 550, 1985.
150. Arrago, J. P., Poirier, O., Chomienne, C., D‘Agay, M. F. D., and Najean, Y., Type III aminoterminal propeptide of procollagen in some haematological malignancies, Scand. J. Haematol., 36, 288, 1986.
151. Najean, Y., Poirier, O., and Arrago, J. P., Interet clinique des dosages du fragment aminoterminal du procollagene III dans les desordres myeloprolifetifs, Nouv. Rev. Fr. HematoL, 29, 123, 1987.
152. Hasselbalch, H., Junker, P., Lisse, I., Bentsen, K. D., Risteli, L., and Risteli, J., Serum markers for type IV collagen and type III procollagen in the myelofibrosis-osteomyelosclerosis syndrome and other chronic myeloproliferative disorders, Am. J. HematoL. 23, 101, 1986.
153. Hprslev-Petersen, K., Bentsen, K. D., Junker, P., and Lorenzen, I., Serum amino-terminal type III procollagen peptide in rheumatoid arthritis, Arthritis Rheum., 29, 592, 1986.
154. Herslev-Petersen, K., Bentsen, K. D., Halberg, P., Junker, P., Kivirikko, K. I., Majamaa, K., Risteli, L., Risteli, J., and Lorenzen, I., Connective tissue metabolites in serum as markers of disease activity in patients with rheumatoid arthritis, Clin. Exp. Rheumatol., 6, 129, 1988.
155. Krieg, T., Langer, I., Gerstmeier, H., Keller, J., Mensing, H., Goerz, G., and Timpl, R., Type III collagen aminopropeptide levels in serum of patients with progressive systemic scleroderma, J. Invest. Dermatol., 87, 788, 1986.
156. Fisher, L. W., Gehron Robey, P., Young, M. F., and Termine, J., Bone glycoproteins, Methods EnzymoL, 145, 269, 1987.
157. Deftos, L. J., Parthemore, J. G., and Price, P. A., Changes in plasma bone Gla protein during treatment of bone disease, Calcif. Tissue Int., 34, 121, 1982.
158. Urist, M. R. and Hudak, R. T., Radioimmunoassay for bone morphogenetic protein in serum: a tissue-specific parameter of bone metabolism, Proc. Soc. Exp. Biol. Med., 176, 472, 1984.
159. Myllylä, R., Myllylä, V. V., Tolonen, U., and Kivirikko, K. I., Changes in collagen metabolism in diseased muscle. I. Biochemical studies., Arch. Neurol., 39, 752, 1982.
160. Kauppila, A., Puistola, U., Risteli, J., and Risteli, L., Aminoterminal propeptide of type III procollagen: a new prognosis indicator in human ovarian cancer, Cancer Res., 49, 1885, 1989.
161. Scher, H. I. and Yagoda, A., Bone metastases: pathogenesis, treatment, and rationale for use of resorption inhibitors, Am. J. Med., 82 (Suppl. 2A), 6, 1987.
162. Blomqvist, C, Elomaa, I., Virkkunen, P., Porkka, L., Karonen, S. -L., Risteli, L., and Risteli, J., Response evaluation of bone metastases in mammary carcinoma. The value of radiology, scintigraphy and biochemical markers of bone metabolism, Cancer, 60, 2907, 1987.
163. Elomaa, I., Risteli, L., and Risteli, J., et al., unpublished.
164. Rochlitz, C, Hasslacher, C, Brocks, D. G., and Herrmann, R., Serum concentration of laminin, and course of the disease in patients with various malignancies, J. Clin. Oncol., 5, 1424, 1987.
165. Hartmann, D. J. and Ville, G., Dosage serique du fragment PI de la laminine humaine, Ann. Biol. Clin., 45, 166, 1987.
166. Danne, T., Grüters, A., Schnabel, K., Burger, W., l‘Allemand, D., Enders, I., Helge, H., and Weber, B., Longterm monitoring of treatment with recombinant human growth hormone by serial determination of type III procollagen related antigens in serum, Pediatr. Res., 23, 167, 1988.
167. Tapanainen, P., Risteli, L., Knip, M., Käär, M. -L. and Risteli, J., Serum aminoterminal propeptide of type III procollagen: a potential predictor of the response to growth hormone therapy, J. Clin. Endocrinol. Metab., 67, 1244, 1988.
168. Trivedi, P., Hindmarsh, P., Risteli, J., Risteli, L., Mowat, A. P., and Brook, C. G. D., Growth velocity, growth hormone treatment and serum concentrations of the aminoterminal propeptide of type III procollagen,/. Pediatr., 114, 225, 1989.
169. Hyams, J. S., Carey, D. E., Leichtner, A. M., and Goldberg, B. D., Type I procollagen as a biochemical marker of growth in children with inflammatory bowel disease, J. Pediatr., 109, 619, 1986.
170. Verde, G. G., Santi, I., Chiodini, P., Cozzi, R., Dallabonzana, D., Oppizzi, G., and Liuzzi, A., Serum type III procollagen propeptide levels in acromegalic patients, J. Clin. Endorinol. Metab., 63, 1406, 1986.
171. Charrie, A. M., Fleury-Goyon, M. C, Dutey, P., and Tourniaire, J., ProcolIagen-III-peptide and hyperthyroidism, Lancet, 2, 1221, 1986.
172. Hasslacher, C. H., Reichenbacher, R., Gechter, F., and Timpl, R., Glomerular basement membrane synthesis and serum concentration of type IV collagen in streptozotocin-diabetic rats, Diabetologia, 26, 150, 1984.
173. Hasslacher, C, Brocks, D., Mann, J., Mall, G., and Waldherr, R., Influence of hypertension on serum concentration of type IV collagen antigens in streptozotocin-diabetic and non-diabetic rats, Diabetologia, 30, 344, 1987.
174. Mellon, C. D., Sasser, B. W., and Bowman, B. H., Increased concentrations of basement membrane collagen fragment in urine of diabetic mice, Biochem. Gen., 22, 631, 1985.
175. Hasslacher, C. and Brocks, D. G., Serum concentration of laminin in type I diabetic patients with and without microangiopathy, Transplant. Proc, 18, 1534, 1986.
176. Högemann, B., Voss, B., Altenwerth, F. J., Schneider, M., Rauterberg, J., and Gerlach, U., Concentrations of 7S collagen and laminin PI in sera of patients with diabetes mellitus, Klin. Wochenschr., 64, 382, 1986.
177. Högemann, B., Voss, B., and Rauterberg, J., 7 S-Kollagen - Serumkonzentrationen eines Basalmem-branfragments bei Patienten mit Diabetes mellitus, Med. Welt., 36, 809, 1985.
178. Högemann, B., Balleisen, L., Rauterberg, J., Voss, B., and Gerlach, U., Basement membrane components (7S collagen, laminin PI) are increased in sera of diabetics and activate platelets in vitro, Hae-mostasis, 16, 428, 1986.